Transformation of Human Leukocytes by Cocultivation with an Adult T Cell Leukemia Virus Producer Cell Line
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The transmission of adult T cell leukemia virus, a human retrovirus, into fresh leukocytes from normal humans was examined. One of three virus-carrying cell lines, tested after being subjected to lethal x-irradiation, consistently transformed leukocytes from adult peripheral blood and umbilical cord blood. All the transformed cell lines expressed adult T cell leukemia virus-associated antigen, but transformed lines originating from adult and umbilical cord blood exhibited T cell and non-T, non-B cell surface natures, respectively. Efforts to transform human leukocytes with cell-free virus were unsuccessful.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HTLV-1 mostly requires cell-to-cell contact for effective transmission [61], with de novo cell-to-cell transmission and contact with bodily fluids containing infected cells being the most common.”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [61]
Citations
Cites
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel Filtration
Mogensen, C. E. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516809076979 · Cited by 2,654
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.481 · Cited by 2,316
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252
Self-citationYoshida, M., Miyoshi, I., & Hinuma, Y. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2031 · Cited by 2,169
Self-citationMiyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., & Hinuma, Y. (1981) · Nature · doi:10.1038/294770a0 · Cited by 1,402
Self-citationHenle, W., Diehl, V., Kohn, G., zur Hausen, H., & Henle, G. (1967) · Science · doi:10.1126/science.157.3792.1064 · Cited by 588
Robert-Guroff, M., Nakao, Y., Notake, K., Ito, Y., Sliski, A., & Gallo, R. C. (1982) · Science · doi:10.1126/science.6760397 · Cited by 358
Letter: Dangerous Australian antigens.
James, D. G. (1975) · PubMed · Cited by 133
A retrovirus associated with human adult T-cell leukemia: in vitro activation.
Hinuma, Y., Gotoh, Y. I., Sugamura, K., Nagata, K., Goto, T., Nakai, M., Kamada, N., Matsumoto, T., & Kinoshita, K.-I. (1982) · PubMed · Cited by 132
Self-citation
Research works printed but not linked: 3
- JPN J CLIN ONCOL 11: 15 (1981).
- CATOVSKY, D, LANCET 1: 640 (1982).
- TAKATSUKI, K, TOPICS HEMATOLOGY: 73 (1977).
Cited by
Items 101–200 of 429
Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus.
Sodroski, J., Trus, M. D., Perkins, D. L., Patarca, R., Wong‐Staal, F., Gelmann, E. P., Gallo, R. C., & Haseltine, W. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4617 · Cited by 76
Dewan, M. Z. (2006) · Blood · doi:10.1182/blood-2005-02-0735 · Cited by 75
Mechanisms of Tax Regulation of Human T Cell Leukemia Virus Type I Gene Expression
Franklin, A. A., & Nyborg, J. K. (1995) · Journal of Biomedical Science · doi:10.1007/bf02257921 · Cited by 75
Functional Relation Between HTLV-II x and Adenovirus E1A Proteins in Transcriptional Activation
Chen, I. S. Y., Cann, A. J., Shah, N. P., & Gaynor, R. B. (1985) · Science · doi:10.1126/science.2996140 · Cited by 74
Adult T‐cell leukemia (ATL) virus‐specific antibodies in atl patients and healthy virus carriers
Yamamoto, N., Schneider, J., Koyanagi, Y., Hinuma, Y., & Hunsmann, G. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910320304 · Cited by 73
Self-citationIntersubunit Disulfide Isomerization Controls Membrane Fusion of Human T-Cell Leukemia Virus Env
Li, K., Zhang, S., Kronqvist, M., Wallin, M., Ekström, M., Derse, D., & Garoff, H. (2008) · Journal of Virology · doi:10.1128/jvi.00448-08 · Cited by 66
“In contrast, cell-free HTLV-1 preparations are known to have very low competence for infectivity (33, 41, 51).”
BackgroundPaul, N. L., Lenardo, M. J., Novak, K. D., Sarr, T., Tang, W. L., & Ruddle, N. H. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5412-5419.1990 · Cited by 71
“Some CD4+ T lymphocytes are immortalized after exposure to ATL-derived HTLV-I (69).”
BackgroundRatner, L., Josephs, S. F., Starcich, B. R., Hahn, B. H., Shaw, G. M., Gallo, R. C., & Wong‐Staal, F. (1985) · Journal of Virology · doi:10.1128/jvi.54.3.781-790.1985 · Cited by 71
“Fourth, the virus can be transmitted rapidly in vitro to normal lymphocytes, resulting in immortalized cell lines with morphological, cytochemical, and biochemical characteristics similar to those found in both primary cell lines and fresh tumor cells (32, 33, 36-39, 65).”
BackgroundExpression of the 3′ Terminal Region of Human T-Cell Leukemia Viruses
Wachsman, W., Shimotohno, K., Clark, S. C., Golde, D. W., & Chen, I. S. Y. (1984) · Science · doi:10.1126/science.6091270 · Cited by 73
Pique, C., Lagaudrière‐Gesbert, C., Delamarre, L., Rosenberg, A. R., Conjeaud, H., & Dokhélar, M. (2000) · Virology · doi:10.1006/viro.2000.0538 · Cited by 68
Enhancement of LFA-1-Mediated T Cell Adhesion by Human T Lymphotropic Virus Type 1 p12I1
Kim, S.-J., Nair, A. M., Fernandez, S., Mathes, L., & Lairmore, M. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5463 · Cited by 60
Feuer, G., Fraser, J. K., Zack, J. A., Lee, F., Feuer, R., & Chen, I. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.4038-4044.1996 · Cited by 62
“Peripheral and cord blood T cells can be infected and immortalized by HTLV-1 in vitro, and transformed cells express high levels of CD25, the interleukin 2 (IL-2) receptor alpha chain (30, 46).”
BackgroundKomuro, A., Watanabe, T., Miyoshi, I., Hayami, M., Tsujimoto, H., Seiki, M., & Yoshida, M. (1984) · Virology · doi:10.1016/0042-6822(84)90364-7 · Cited by 66
Matsumoto, C., Mitsunaga, S., Oguchi, T., Mitomi, Y., Shimada, T., Ichikawa, A., Watanabe, J., & Nishioka, K. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5290-5294.1990 · Cited by 65
“For these purposes, cocultivation with HTLV-I-noninfected T cells (16, 27) and detection of the HTLV-I genome (14, 28) have been considered.”
MethodExpression of a Zinc Finger Gene in HTLV-I- and HTLV-II-Transformed Cells
Wright, J. J., Gunter, K. C., Mitsuya, H., Irving, S. G., Kelly, K., & Siebenlist, U. K. (1990) · Science · doi:10.1126/science.2110381 · Cited by 65
Transformation of rabbit lymphocytes with T-cell leukemia virus.
Miyoshi, I., Yoshimoto, S., Taguchi, H., Kubonishi, I., Fujishita, M., Ohtsuki, Y., Shiraishi, Y., & Akagi, T. (1983) · PubMed · Cited by 65
Mori, N., Matsuda, T., Tadano, M., Kinjo, T., Yamada, Y., Tsukasaki, K., Ikeda, S., Yamasaki, Y., Tanaka, Y., Ohta, T., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4582-4590.2004 · Cited by 60
“HTLV-1-infected T-cell lines MT-2 (30), MT-4 (56), SLB-1 (24), C5/MJ (43),”
Self-citationRetractedRatner, L., Starcich, B. R., Josephs, S. F., Hahn, B. H., Reddy, E. P., Livak, K. J., Petteway, S. R., Pearson, M. L., Haseltine, W. A., Arya, S. K., et al. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.22.8219 · Cited by 63
HTLV x -Gene Product: Requirement for the env Methionine Initiation Codon
Wachsman, W., Golde, D. W., Temple, P. A., Orr, E. C., Clark, S. C., & Chen, I. S. Y. (1985) · Science · doi:10.1126/science.2990032 · Cited by 58
Human leukemia virus associated with adult T-cell leukemia.
Yoshida, M. (1983) · PubMed · Cited by 62
Richardson, J. H., Höllsberg, P., Windhagen, A., Child, L. A., Hafler, D. A., & Lever, A. M. L. (1997) · Blood · doi:10.1182/blood.v89.9.3303 · Cited by 60
Modeling the T-cell Dynamics and Pathogenesis of HTLV-I Infection
Stilianakis, N. I., & Seydel, J. (1999) · Bulletin of Mathematical Biology · doi:10.1006/bulm.1999.0117 · Cited by 58
Sawada, L., Nagano, Y., Hasegawa, A., Kanai, H., Nogami, K., Ito, S., Sato, T., Yamano, Y., Tanaka, Y., Masuda, T., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006597 · Cited by 58
Self-citationHausen, H. Z. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00113-6 · Cited by 57
Merl, S., Kloster, B., Moore, J., Hubbell, C., Tomar, R., Davey, F., Kalinowski, D., Planas, A., Ehrlich, G., & Clark, D. (1984) · Blood · doi:10.1182/blood.v64.5.967.967 · Cited by 50
Human T-Lymphotropic Virus Type 1 (HTLV-1): Persistence and Immune Control
Bangham, C. R. M. (2003) · International Journal of Hematology · doi:10.1007/bf02983553 · Cited by 55
“It has been known since the discovery of HTLV-1 that close cell contact is required for efficient transmission of the virus both in vivo [51] and in vitro [52, 53 ].”
BackgroundThe human T-cell leukemia virus (HTLV) transactivator (tax) protein
Sodroski, J. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(92)90003-h · Cited by 55
Expression of a Provirus of Human T Cell leukaemia Virus Type I by DNA Transfection
Mori, K. J., Sabe, H., Siomi, H., Iino, T., Tanaka, A., Takeuchi, K., Hirayoshi, K., & Hatanaka, M. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-2-499 · Cited by 55
Human Retroviruses: HTLV-I and HTLV-II
Sugamura, K., & Hinuma, Y. (1993) · Springer eBooks · doi:10.1007/978-1-4899-1627-3_7 · Cited by 55
Self-citationMiyazato, P., Yasunaga, J.-I., Taniguchi, Y., Koyanagi, Y., Mitsuya, H., & Matsuoka, M. (2006) · Journal of Virology · doi:10.1128/jvi.01009-06 · Cited by 54
Self-citationBlanc, I., Rosenberg, A. R., & Dokhélar, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1860-1867.1999 · Cited by 54
“HTLV-1 transmission in vitro (30, 48) and in vivo (9, 26) requires contact with infected cells, cell-free particles are very weakly (or not) infectious, possibly because they are very fragile.”
BackgroundT-Cell Transformation and Oncogenesis by γ2-Herpesviruses
Ensser, A., & Fleckenstein, B. (2005) · Advances in cancer research · doi:10.1016/s0065-230x(05)93003-0 · Cited by 53
Molecular Features of the Human T-Cell Leukemia Virus
Green, P. L., & Chen, I. S. Y. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1730-0_6 · Cited by 53
Human T-cell leukemia virus types I and II exhibit different DNase I protection patterns
Altman, R. L., Harrich, D., Garcia, J. A., & Gaynor, R. B. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1339-1346.1988 · Cited by 53
Expression of the HTLV-1 genome and its association with a unique T-cell malignancy
Yoshida, M. (1987) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(87)90003-5 · Cited by 52
Tomita, M., Semenza, G. L., Michiels, C., Matsuda, T., Uchihara, J.-N., Okudaira, T., Tanaka, Y., Taira, N., Ohshiro, K., & Mori, N. (2007) · Biochemical Journal · doi:10.1042/bj20070286 · Cited by 46
RetractedTsubata, C., Higuchi, M., Takahashi, M., Oie, M., Tanaka, Y., Gejyo, F., & Fujii, M. (2005) · Retrovirology · doi:10.1186/1742-4690-2-46 · Cited by 48
“HTLV-1 is an oncoretrovirus, which immortalizes human CD4 T-cells in vitro [3,4].”
BackgroundHarada, S., Yoshiyama, H., & Yamamoto, N. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.6.908-911.1985 · Cited by 51
“This may be a common feature of human retroviruses which share tropism for OKT4-positive lymphocytes (8, 14).”
BackgroundSelf-citationHuman T‐cell leukemia virus (HTLV‐I) p24 antibody in New York City blood product recipients
Jason, J. M., McDougal, J. S., Cabradilla, C., Kalyanaraman, V. S., & Evatt, B. L. (1985) · American Journal of Hematology · doi:10.1002/ajh.2830200205 · Cited by 46
Pan, X., Chen, Y., & Shu, H. (2019) · Journal of Mathematical Analysis and Applications · doi:10.1016/j.jmaa.2019.07.051 · Cited by 50
Mori, N., Fujii, M., Hinz, M., Nakayama, K., Yamada, Y., Ikeda, S., Yamasaki, Y., Kashanchi, F., Tanaka, Y., Tomonaga, M., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10388 · Cited by 50
Self-citationSelective cytotoxicity of aids virus infection towards HTLV‐I‐transformed cell lines
Koyanagi, Y., Harada, S., Yamamoto, N., Takahashi, M., & Uchino, F. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910360406 · Cited by 50
Self-citationInduction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity
Gauthier, S., Pelletier, I., Ouellet, M., Vargas, A., Tremblay, M. J., Sato, S., & Barbeau, B. (2008) · Retrovirology · doi:10.1186/1742-4690-5-105 · Cited by 49
Human T‐cell leukaemia virus (HTLV) in the United Kingdom
Greaves, M. F., Verbi, W., Tilley, R., Lister, T. A., Habeshaw, J. A., Guo, H., Trainor, C. D., Robert-Guroff, M., Blattner, W. A., Reitz, M. S., et al. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330614 · Cited by 49
Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma
Ishikawa, C., Senba, M., & Mori, N. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172953 · Cited by 48
Sakai, M., Eguchi, K., Terada, K., Nakashima, M., Yamashita, I., Ida, H., Kawabe, Y., Aoyagi, T., Takino, H., & Nakamura, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116789 · Cited by 48
Mechanisms of human T-cell leukemia virus-induced leukemogenesis
Feuer, G., & Chen, I. S. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(92)90017-s · Cited by 48
Koralnik, I. J., Mulloy, J. C., Andrésson, Þ., Fullen, J., & Franchini, G. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-8-1909 · Cited by 48
von Rüden, T., & Gilboa, E. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.677-682.1989 · Cited by 48
“This virus transforms in vitro primary human T cells derived from umbilical cord blood (18, 28, 41) or bone marrow (19), although it does not carry a typical onc gene.”
BackgroundGlowacka, I., Korn, K., Potthoff, S. A., Lehmann, U., Kreipe, H. H., Ivens, K., Barg‐Hock, H., Schulz, T. F., & Heim, A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit545 · Cited by 46
“HTLV-1 is highly cell associated [7].”
Leukaemogenic mechanism of human T‐cell leukaemia virus type I
Yasunaga, J., & Matsuoka, M. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.548 · Cited by 46
Possible Viral Interactions in the Acquired Immunodeficiency Syndrome (AIDS)
Hirsch, M., Schooley, R. T., Ho, D. D., & Kaplan, J. C. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.5.726 · Cited by 46
“EBVinfected B cell lines may also support infection with HTLV [33].”
BackgroundKampani, K., Quann, K., Ahuja, J., Wigdahl, B. L., Khan, Z. K., & Jain, P. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2006.11.043 · Cited by 44
“HTLV-1 infection by cell-to-cell contact is more efficient than cellfree infection (Clapham et al., 1983;de Rossi et al., 1985; Fan et al., 1992; Yamamoto et al., 1982); however, studies pertinent to virus binding need to be performed with purified virus in order to model critical events during early infection when vi…”
BackgroundHoppe‐Seyler, F., & Butz, K. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00195138 · Cited by 43
“Its transforming potential is reflected by its ability to immortalize human T cells in vitro [55, 88 ].”
BackgroundTanaka, Y., Lee, B., Inoi, T., Tozawa, H., Yamamoto, N., & Hinuma, Y. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910370107 · Cited by 42
Self-citationTochikura, T. S., Iwahashi, M., Matsumoto, T., Koyanagi, Y., Hinuma, Y., & Yamamoto, N. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910360102 · Cited by 43
Self-citationOhashi, T., Hanabuchi, S., Kato, H., Koya, Y., Takemura, F., Hirokawa, K., Yoshiki, T., Tanaka, Y., Fujii, M., & Kannagi, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6031-6040.1999 · Cited by 43
Self-citationMilk‐Borne Transmission of HTLV‐I as a Major Route in the Endemic Cycle
Hino, S. (1989) · Pediatrics International · doi:10.1111/j.1442-200x.1989.tb01329.x · Cited by 42
Sodroski, J., Goh, W. C., Rosen, C. A., Salahuddin, S. Z., Aldovini, A., Franchini, G., Wong‐Staal, F., Gallo, R. C., Sugamura, K., & Hinuma, Y. (1985) · Journal of Virology · doi:10.1128/jvi.55.3.831-835.1985 · Cited by 42
“This hypothesis can explain the ability of HTLV-I and HTLV-II to immortalize primary human T-lymphocytes in vitro (3, 18, 21, 37) and the lack of specific provirus integration sites in ATLL tumors (12, 26).”
BackgroundSelf-citationNakamura, H., Tanaka, Y., Komuro, A., Ishikawa, K.-I., Takadaya, K., Tozawa, H., Tsujimoto, H., Honjo, S., & Hayami, M. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380614 · Cited by 42
Healthy HTLV‐I carriers in Japan: the haematological and immunological characteristics
Yasuda, K., Sei, Y., YOKOYAMA, M. M., Tanaka, K., & Har, A. (1986) · British Journal of Haematology · doi:10.1111/j.1365-2141.1986.tb07587.x · Cited by 42
Mori, N., Krensky, A. M., Ohshima, K., Tomita, M., Matsuda, T., Ohta, T., Yamada, Y., Tomonaga, M., Ikeda, S., & Yamamoto, N. (2004) · International Journal of Cancer · doi:10.1002/ijc.20266 · Cited by 41
Self-citationYao, J., & Wigdahl, B. (2000) · Frontiers in bioscience · doi:10.2741/yao · Cited by 41
Expression of Survivin in HTLV-I-Infected T-Cell Lines and Primary ATL Cells
Mori, N., Yamada, Y., Hata, T., Ikeda, S., Yamasaki, Y., Tomonaga, M., & Yamamoto, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4708 · Cited by 41
Self-citationPersaud, D., Muñoz, J. L., Tarsis, S. L., Parks, E. S., & Parks, W. P. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6297-6303.1995 · Cited by 41
“Human T-cell lymphotropic virus type 1 (HTLV-1), the etiologic agent of adult T-cell leukemia (ATL) (6, 12, 13, 22, 34) and HTLV-1-associated myelopathy or tropical spastic paraparesis (9, 21), causes T-lymphocyte transformation in vitro (4, 18, 30, 33).”
BackgroundPanfil, A. R., Dissinger, N. J., Howard, C. M., Murphy, B. M., Landes, K., Fernandez, S. A., & Green, P. L. (2016) · Journal of Virology · doi:10.1128/jvi.03113-15 · Cited by 39
“to-cell contact (9, 10), and both viruses are capable of transforming T”
BackgroundIn vitro infection of human macrophages with human T-cell leukemia virus type 1
de Revel, T., Mabondzo, A. M., Gras, G. S., Delord, B., Roques, P., Boussin, F. D., Neveux, Y., Bahuau, M., Fleury, H. J., & Dormont, D. (1993) · Blood · doi:10.1182/blood.v81.6.1598.1598 · Cited by 39
Subnuclear localization of the trans-activating protein of human T-cell leukemia virus type I
Slamon, D. J., Boyle, W. J., Keith, D. E., Press, M. F., Golde, D. W., & Souza, L. M. (1988) · Journal of Virology · doi:10.1128/jvi.62.3.680-686.1988 · Cited by 39
“The etiologic agent for this disease is believed to be human T-cell leukemia virus type I (HTLV-I) (22, 34, 36, 55).”
BackgroundOrita, S., Saiga, A., Takagi, S., Tanaka, T., Okumura, K., Aono, Y., Hinuma, Y., & Igarashi, H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81402-t · Cited by 39
Self-citationRole of HTLV-1 orf-I encoded proteins in viral transmission and persistence
Sarkis, S., Galli, V., Moles, R., Yurick, D., Khoury, G., Purcell, D. F. J., Franchini, G., & Pise-Masison, C. A. (2019) · Retrovirology · doi:10.1186/s12977-019-0502-1 · Cited by 38
Ishikawa, C., Nakachi, S., Senba, M., Sugai, M., & Mori, N. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq222 · Cited by 38
Interleukin 2 inhibits in vitro growth of human T cell lines carrying retrovirus.
Sugamura, K., Nakai, S., Fujii, M., & Hinuma, Y. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.5.1243 · Cited by 38
“This change from IL-2 dependence to IL-2 independence could be due to immortalizing transformation of the cells induced by HTLV (9, 10).”
BackgroundSelf-citationAnalysis of a within-host HIV/HTLV-I co-infection model with immunity
Elaiw, A. M., & AlShamrani, N. H. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198204 · Cited by 37
Ishikawa, C., Arbiser, J. L., & Mori, N. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.009 · Cited by 37
Zimmerman, B., Sargeant, A., Landes, K., Fernandez, S. A., Chen, C.-S., & Lairmore, M. D. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.07.015 · Cited by 36
Ishioka, K., Higuchi, M., Takahashi, M., Yoshida, S., Oie, M., Tanaka, Y., Takahashi, S., Xie, L., Green, P. L., & Fujii, M. (2006) · Retrovirology · doi:10.1186/1742-4690-3-71 · Cited by 32
“latent period of 60–70 years [1-3,6,7].”
Rosenberg, A. R., Delamarre, L., Pique, C., Pham, D., & Dokhélar, M. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7180-7186.1997 · Cited by 36
“Likewise, in vitro infection by HTLV-1 usually requires cocultivation of target cells with infected cells (24, 72), and cell-free infection, although successfully achieved in some experimental systems, is very inefficient compared with that of other retroviruses (19, 27, 34).”
ResultMiyamoto, K., Tomita, N., Ishii, A., Nishizaki, T., Kitajima, K., Tanaka, T., Nakamura, T., Watanabe, S., & Oda, T. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330603 · Cited by 35
Matsuda, T., Almasan, A., Tomita, M., Uchihara, J., Masuda, M., Ohshiro, K., Takasu, N., Yagita∥, H., Ohta, T., & Mori, N. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1367-1378.2005 · Cited by 34
“MT-2, MT-4, C5/MJ, and SLB-1 are HTLV-1-transformed T-cell lines.”
InfluentialRetractedNakamura, N., Fujii, M., Tsukahara, T., Arai, M., Ohashi, T., Wakao, H., Kannagi, M., & Yamamoto, N. (1999) · Oncogene · doi:10.1038/sj.onc.1202608 · Cited by 34
“Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent of ATL (Hinuma et al., 1981; Poiesz et al., 1980), and it transforms CD4 positive T-cells in vitro (Miyoshi et al., 1981; Yamamoto et al., 1982).”
BackgroundSelf-citationThe Cytoplasmic Tail of Retroviral Envelope Glycoproteins
Tedbury, P. R., & Freed, E. O. (2014) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.10.009 · Cited by 33
Hayami, M., Tsujimoto, H., Komuro, A., Hinuma, Y., & Fujiwara, K. (1984) · PubMed · Cited by 33
Self-citationAl-Fahim, A., Cabre, P., Kastrukoff, L. F., Dorovini‐Zis, K., & Oger, J. J.-F. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1580 · Cited by 32
Ida, H., Kurata, A., Eguchi, K., Yamashita, I., Nakashima, M., Sakai, M., Kawabe, Y., Nakamura, T., & Nagataki, S. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90041-8 · Cited by 32
Experimental infection of cynomolgus monkeys with a human retrovirus, adult T-cell leukemia virus
Yamamoto, N., Hayami, M., Komuro, A., Schneider, J., Hunsmann, G., Okada, M., & Hinuma, Y. (1984) · Medical Microbiology and Immunology · doi:10.1007/bf02123570 · Cited by 32
“The association of ATLV with malignancy is based on seroepidemiological studies (Hinuma et al. 1981, 1982), the demonstration of the ATLV genome in tumor cells (Yoshida et al. 1982) and the ability of ATLV~containing cells to immortalize human (Miyoshi et al. 1981 ; Yamamoto et al. 1982a ) and simian lymphocytes in vi…”
BackgroundSelf-citationGlobal dynamics of a mathematical model for HTLV-I infection of CD4+ T-cells
Cai, L., Li, X.-Z., & Ghosh, M. (2011) · Applied Mathematical Modelling · doi:10.1016/j.apm.2011.01.033 · Cited by 31
“Infection by HTLV-I is characterized by cell-to-cell infection [ 1 ], [2], [3] of CD4+ T cells which HTLV-I prefer-”
Nomura, M., Ohashi, T., Nishikawa, K., Nishitsuji, H., Kurihara, K., Hasegawa, A., Furuta, R. A., Fujisawa, J.-I., Tanaka, Y., Hanabuchi, S., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.3827-3836.2004 · Cited by 31
“The HTLV-1 has been shown to activate and immortalize human T cells in vitro, resulting in polyclonal proliferation of infected cells and subsequent oligoclonal or monoclonal growth (11, 52).”
BackgroundSelf-citationNiinuma, A., Higuchi, M., Takahashi, M., Oie, M., Tanaka, Y., Gejyo, F., Tanaka, N., Sugamura, K., Xie, L., Green, P. L., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11925-11934.2005 · Cited by 30
“Both HTLV-1 and HTLV-2 immortalize primary human T cells with similar efficiency in vitro (8, 27, 41), and like”
BackgroundEvaluation of passive particle agglutination test for antibody to human immunodeficiency virus
Yoshida, T., Matsui, T., Kobayashi, S. S., & Yamamoto, N. (1987) · Journal of Clinical Microbiology · doi:10.1128/jcm.25.8.1433-1437.1987 · Cited by 30
“HIV is considered to destroy T lymphocytes in vivo, inducing immune deficiency (16), whereas HTLV-I causes T-cell transformation (18), resulting in leukemia or lymphoma (9) after a long latency period.”
Self-citationTsujimoto, H., Seiki, M., Nakamura, H., Watanabe, T., Sakakibara, I., Sasagawa, A., Honjo, S., Hayami, M., & Yoshida, M. (1985) · PubMed · Cited by 30
Structural Analysis of p28 Adult T-Cell Leukaemia-associated Antigen
Iino, T., Takeuchi, K., Nam, S. H., Siomi, H., Sabe, H., Kobayashi, N., & Hatanaka, M. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-7-1373 · Cited by 29
Immortalization of peripheral blood lymphocytes of cats by human T‐cell leukemia virus
Hoshino, H., Tanaka, H., Shimotohno, K., Miwa, M., Nagai, M., Shimoyama, M., & Sügimura, T. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340414 · Cited by 29
Okudaira, T., Hirashima, M., Ishikawa, C., Makishi, S., Tomita, M., Matsuda, T., Kawakami, H., Taira, N., Ohshiro, K., Masuda, M., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22534 · Cited by 28
RetractedTozawa, H., Andoh, S., Takayama, Y., Tanaka, Y., Lee, B., Nakamura, H., Hayami, M., & Hinuma, Y. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410213 · Cited by 28
Self-citation3 Growth Transformation of Human T Cells
Fickenscher, H., & Fleckenstein, B. (1998) · Methods in microbiology · doi:10.1016/s0580-9517(08)70693-7 · Cited by 28
Melief, C. J. M., & Goudsmit, J. (1986) · Vox Sanguinis · doi:10.1111/j.1423-0410.1986.tb04837.x · Cited by 28
Kawakami, H., Tomita, M., Okudaira, T., Ishikawa, C., Matsuda, T., Tanaka, Y., Nakazato, T., Taira, N., Ohshiro, K., & Mori, N. (2007) · International Journal of Cancer · doi:10.1002/ijc.22403 · Cited by 27
RetractedIshikawa, C., Matsuda, T., Okudaira, T., Tomita, M., Kawakami, H., Tanaka, Y., Masuda, M., Ohshiro, K., Ohta, T., & Mori, N. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06445.x · Cited by 27
“The HTLV-I-negative human T-cell leukaemia cell lines, Jurkat and MOLT-4, and HTLV-I-infected T-cell lines, MT-4 (Yamamoto et al, 1982), C5/MJ (Popovic et al, 1983), SLB-1 (Koeffler et al, 1984) and HUT-102 (Poiesz et al, 1980) were cultured in Roswell Park Memorial Institute 1640 medium…”
MethodDistinct Reactivities of Four Monoclonal Antibodies with Human Interleukin 2 Receptor
Tanaka, Y., Tozawa, H., Hayami, M., Sugamura, K., & Hinuma, Y. (1985) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1985.tb02960.x · Cited by 27
Self-citationViral Transformation Of Human T Lymphocytes
Grassmann, R., Fleckenstein, B., & Desrosiers, R. C. (1994) · Advances in cancer research · doi:10.1016/s0065-230x(08)60401-7 · Cited by 26
Metadata
- Authors
- Yamamoto, N., Okada, M., Koyanagi, Y., Kannagi, M., & Hinuma, Y.
- Affiliations
- Kyoto University (JP)
- Venue
- Science
- Published
- 1982-08-20
- Volume
- 217
- Issue
- 4561
- Pages
- 737-739
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2123679031
- Cited by
- 398
- References
- 10
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 7 · 2023: 6 · 2022: 3 · 2021: 7 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 1 · 2014: 6 · 2013: 6 · 2012: 2
- FWCI
- 15.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- adult T-cell leukemia virus, leukocyte transformation, co-culture, virus transmission, peripheral blood leukocytes, umbilical cord blood, T-cell markers, cell-free virus, retroviruses
- MeSH terms
- Antigens, Surface, Antigens, Viral, B-Lymphocytes, Cell Line, Fetal Blood, Genes, Viral, Humans, Karyotyping, Leukocytes, Retroviridae, T-Lymphocytes, Transformation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.